Andi Xu

Andi Xu

Auto-generated profile, based on publicly available information

Andi Xu

Department of Pathology, Nanjing Drum Tower Hospital, China (A.X.).

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2022 in Epigenomics
Verified
Journal Article
Closed access
TQTianye Qian
Tianye Qian
XYXinnian Yu
Xinnian Yu
AXAndi Xu
Andi Xu
HLHuixin Li
Huixin Li
WCWei Chen
Wei Chen
SZShanliang Zhong
Shanliang Zhong
Aim: To explore the roles of transfer RNA-derived small RNAs (tsRNAs) in endometrial carcinoma (EC). Materials & methods: tsRNA profiles for EC from TCGA were analyzed. The functions and mechanisms...

16 August 2024 in Circulation Research
Verified
Journal Article
Closed access
LZLai Zhang
Lai Zhang
HHHuian Han
Huian Han
AXAndi Xu
Andi Xu
ASAdwait Sathe
Adwait Sathe
SFSiying Fu
Siying Fu
QCQi Chen
Qi Chen
BACKGROUND: Macrophages are key players in obesity-associated cardiovascular diseases, which are marked by inflammatory and immune alterations. However, the pathophysiological mechanisms underlying macrophage’s role in obesity-induced cardiac inflammation are incompletely understood. Our study aimed to identify the key macrophage population involved in obesity-induced cardiac dysfunction and investigate the molecular mechanism that contributes to the inflammatory response. METHODS: In this study, we used single-cell RNA-sequencing analysis of Cd45 + CD11b + F4/80 + cardiac macrophages to explore the heterogeneity of cardiac macrophages. The CCR2 + (C-C chemokine receptor 2) macrophages were specifically removed by a dual recombinase approach, and the macrophage CCR2 was deleted to investigate their functions. We also performed cleavage under target and tagmentation analysis, chromatin immunoprecipitation-polymerase chain reaction, luciferase assay, and macrophage-specific lentivirus transfection to define the impact of lysozyme C in macrophages on obesity-induced inflammation. RESULTS: We find that the Ccr2 cluster undergoes a functional transition from homeostatic maintenance to proinflammation. Our data highlight specific changes in macrophage behavior during cardiac dysfunction under metabolic challenge. Consistently, inducible ablation of CCR2 + CX3CR1 + macrophages or selective deletion of macrophage CCR2 prevents obesity-induced cardiac dysfunction. At the mechanistic level, we demonstrate that the obesity-induced functional shift of CCR2-expressing macrophages is mediated by the CCR2/activating transcription factor 3/lysozyme 1/NF-κB (nuclear factor kappa B) signaling. Finally, we uncover a noncanonical role for lysozyme 1 as a transcription activator, binding to the RelA promoter, driving NF-κB signaling, and strongly promoting inflammation and cardiac dysfunction in obesity. CONCLUSIONS: Our findings suggest that lysozyme 1 may represent a potential target for the diagnosis of obesity-induced inflammation and the treatment of obesity-induced heart disease.

8 May 2022 in Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology
Verified
Journal Article
Closed access
AXA D Xu
A D Xu
YFY Fu
Y Fu
XZX S Zhao
X S Zhao
XFXiangshan Fan
Xiangshan Fan